# US 2017/0281527 A1 · Mineral based compositions and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281527 A1
- Document ID: US20170281527A1
- Status: Published application
- Kind: A1
- Application number: 15/511,579
- Filed: 2015-09-21
- Published: 2017-10-05
- Earliest claimed: 2014-09-23
- Assignees: Anjon Biologics, Inc.
- Applicants: Anjon Biologics, Inc.
- Inventors: Raziel RONEN
- Web page: https://patentgrep.com/patent/US20170281527A1

## CPC

- A61K 8/97: from algae, fungi, lichens or plants; from derivatives thereof
- A61K 8/19: containing inorganic ingredients
- A61K 8/23: Sulfur; Selenium; Tellurium; Compounds thereof
- A61K 8/25: Silicon; Compounds thereof
- A61K 8/27: Zinc; Compounds thereof
- A61K 8/36: Carboxylic acids; Salts or anhydrides thereof
- A61K 8/4946: {Imidazoles or their condensed derivatives, e.g. benzimidazoles}
- A61K 8/671: {Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal}
- A61K 8/678: {Tocopherol, i.e. vitamin E}
- A61K 8/922: {of vegetable origin}
- A61K 8/965: {of inanimate origin}
- A61K 31/4166: having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 33/30: Zinc; Compounds thereof
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61P 35/00: Antineoplastic agents
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Mineral-based composition and methods of use thereof in preventing skin damages, such as in subjects exposed to radiation, are provided.

## Claims

### Claim 1

A hypotonic composition having a pH of less than 7, the composition comprises:
(i) an allantoin;
(ii) selenium (Se) and zinc (Zn); and
(iii) a carrier.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising a plurality of minerals comprising potassium (K), calcium (Ca), magnesium (Mg), sulfate (SO4), bromide (Br), manganese (Mn), copper (Cu), sulfur (S), tellurium (Te), iron (Fe), sodium (Na) of less than 1000 mg/l and chloride of less than 500 mg/l, silica (SiO2) and bicarbonate.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said selenium (Se) has a concentration of 40-1000 mg/l, and said zinc (Zn) has a concentration of 4-1000 mg/l.

### Claim 4 (depends on 1)

The composition of claim 1, comprising said allantoin in an amount of 0.1-5% by weight.

### Claim 5 (depends on 2)

The composition of claim 2, comprising said plurality of minerals in an amount of 0.001-5% by weight.

### Claim 6 (depends on 1)

The composition of claim 1 having a pH in the range of 5-7.

### Claim 7 (depends on 2)

The composition of claim 2, wherein the sodium levels are less than 500 mg/l.

### Claim 8 (depends on 2)

The composition of claim 2, wherein the chloride levels are less than 150 mg/l.

### Claim 9 (depends on 2)

The composition of claim 2, wherein said plurality of minerals consists of 50-500 mg/l of sodium, 25000-40000 mg/l potassium, 5000-120000 mg/l calcium, 20000-30000 mg/l magnesium, 50-150 mg/l chloride, 2000-2500 mg/l sulfate, 85-100 mg/l bromide, 5-70 mg/l manganese, 10-50 mg/l copper, 3-80 mg/l sulfur, 5-50 mg/l silica, 10-800 mg/l bicarbonate and 0.05-0.5 mg/l tellurium.

### Claim 10 (depends on 1)

The composition according to claim 1, wherein the carrier is selected from the group consisting of jojoba oil, coconut oil, aloe vera gel, cocoa butter, lecithin, almond oil, borage oil, canola oil, grape seed oil, olive oil, soybean oil, sunflower oil, wheat germ oil, apricot kernel oil, carrot oil, mango butter, evening primrose oil, black currant oil, avocado oil, macrocrystalline wax, paraffin, petrolatum, ozokerite, montan wax, beeswax, lanolin or a derivative, candelilla wax, ouricury wax, carnauba wax, Japan wax, cocoa butter, sugarcane wax, cork fiber wax, and mixtures thereof.

### Claim 11 (depends on 1)

The composition according to claim 1, wherein the carrier is selected from jojoba oil, coconut oil, aloe vera gel, and mixtures thereof.

### Claim 12 (depends on 1)

The composition of claim 1, further comprising a compound selected from the group consisting of vitamin E, vitamin A, benzoic acid, benzyl alcohol, cetyl alcohol, citric acid, glycerin, imidazolidinyl urea, isopropyl myristate, methylisothiazolinone, shea butter, sorbitan tristearate and derivatives or combinations thereof.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the composition is in the form of a cream, an ointment, a gel, lotion, liniment, paste or an emulsion.

### Claim 14 (depends on 1)

The composition of claim 1, formulated as a topical composition.

### Claim 15 (depends on 1)

The composition of claim 1, for preventing or reducing damage to skin of a subject undergoing radiotherapy or laser treatment.

### Claim 16 (depends on 1)

The composition of claim 1, for preventing or reducing skin cancer occurrence or reoccurrence.

### Claim 17

A method of preventing or reducing skin damage in a subject in need thereof, the method comprises:
topically applying to the skin of the subject an effective amount of a hypotonic composition having a pH of less than 7 and comprising:
(i) an allantoin;
(ii) selenium (Se) and zinc (Zn); and
(iii) a carrier.

### Claim 18 (depends on 17)

The method of claim 17, wherein said skin damage is caused by exposure to radiation or laser.

### Claim 19 (depends on 17)

The method of claim 17, wherein said subject is undergoing radiotherapy.

### Claim 20 (depends on 19)

The method of claim 19, wherein said radiotherapy is external-beam radiation therapy.

### Claim 21 (depends on 17)

The method of claim 17, for preventing skin cancer occurrence or reoccurrence.

### Claim 22 (depends on 17)

The method of claim 17, wherein said composition is adsorbed to the skin of the subject prior to said radiotherapy.

### Claim 23

A process for preparing a topical formulation comprising the steps of:
(i) providing a mineral-based compositions comprising selenium (Se) and zinc (Zn);
(ii) mixing said mineral-based composition with a carrier at a temperature less than 10° C.; and
(iii) mixing the composition of step (ii) with at least one additional ingredient selected from vitamin E, vitamin A, aloe-vera leaf and allantoin at a temperature less than 10° C.

### Claim 24 (depends on 23)

The process of claim 23 wherein said aloe-vera leaf and allantoin are mixed together at a temperature less than 10° C. prior to step (iii).

### Claim 25 (depends on 23)

The process of claim 23, wherein said temperature less than 10° C. is about 5° C.

### Claim 26 (depends on 23)

The process of claim 23, wherein said mixing is homogenizing.

### Claim 27 (depends on 23)

The process of claim 23, wherein said providing the mineral based composition comprises partially desalinating mineral water.

### Claim 28 (depends on 23)

The process of claim 23, wherein said formulation has a pH level in the range of 5-7.

### Claim 29 (depends on 28)

The process of claim 28, wherein said lowering pH level is by adding citric acid or a derivative thereof to the mineral-based composition of (i).
